100 related articles for article (PubMed ID: 7061860)
1. Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity.
Wetsel RA; Kolb WP
J Immunol; 1982 May; 128(5):2209-16. PubMed ID: 7061860
[No Abstract] [Full Text] [Related]
2. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
Wetsel RA; Kolb WP
J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
[TBL] [Abstract][Full Text] [Related]
3. Fifth component of guinea pig complement: purification and characterization.
Kinoshita T; Hong K; Kondo K; Inoue K
J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of human C5 by trypsin: characterization of the digestion products by gel electrophoresis.
Minta JO; Man DP
J Immunol; 1977 Nov; 119(5):1597-1602. PubMed ID: 410877
[TBL] [Abstract][Full Text] [Related]
5. Oxidants generated by the myeloperoxidase-halide system activate the fifth component of human complement, C5.
Vogt W; Hesse D
Immunobiology; 1994 Dec; 192(1-2):1-9. PubMed ID: 7750983
[TBL] [Abstract][Full Text] [Related]
6. Purification of the third and fifth components of human complement: application of hydrophobic chromatography.
Kunkel SL; Kreutzer DL; Goralnick S; Ward PA
J Immunol Methods; 1980; 35(3-4):337-51. PubMed ID: 7400588
[No Abstract] [Full Text] [Related]
7. Generation of biologic activity from the purified alpha-chain of C5.
Phan SH; Ward PA
J Immunol; 1979 Dec; 123(6):2735-40. PubMed ID: 501087
[TBL] [Abstract][Full Text] [Related]
8. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
Shingu M; Nobunaga M
Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
[TBL] [Abstract][Full Text] [Related]
9. Biologically active complement (C5)-derived peptides and their relevance to disease.
Perez HD
Crit Rev Oncol Hematol; 1984; 1(3):199-225. PubMed ID: 6241542
[TBL] [Abstract][Full Text] [Related]
10. Purification of the fourth, second and fifth components of mouse complement.
Fukuoka Y; Seino J; Okuda T; Tachibana T
Immunology; 1984 Mar; 51(3):493-501. PubMed ID: 6698577
[TBL] [Abstract][Full Text] [Related]
11. Limited proteolysis of C5b-6: functional stability of the degraded complex.
Podack ER; Müller-Eberhard HJ
J Immunol; 1980 Jan; 124(1):332-6. PubMed ID: 6444229
[No Abstract] [Full Text] [Related]
12. Cleavage of the fifth component of human complement and release of a split product with C5a-like activity by crystalline silica through free radical generation and kallikrein activation.
Governa M; Fenoglio I; Amati M; Valentino M; Bolognini L; Coloccini S; Volpe AR; Carmignani M; Fubini B
Toxicol Appl Pharmacol; 2002 Mar; 179(3):129-36. PubMed ID: 11906242
[TBL] [Abstract][Full Text] [Related]
13. Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.
Orr W; Phan SH; Varani J; Ward PA; Kreutzer DL; Webster RO; Henson PM
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1986-9. PubMed ID: 287038
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and post-synthetic modification of a precursor (pro-C5) of the fifth component of mouse complement (C5).
Ooi YM; Colten HR
J Immunol; 1979 Dec; 123(6):2494-8. PubMed ID: 501083
[TBL] [Abstract][Full Text] [Related]
15. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
Low PJ; Ai R; Ogata RT
J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different blood parameters for evaluation of complement activation during hemodialysis.
Gardinali M; Cicardi M; Bergamaschini L; Frangi D; Franzinelli M; Anelli A; Brancaccio D; Agostoni A
Trans Am Soc Artif Intern Organs; 1985; 31():42-4. PubMed ID: 3837483
[No Abstract] [Full Text] [Related]
17. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
Meuer S; Ecker U; Hadding U; Bitter-Suermann D
J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973
[TBL] [Abstract][Full Text] [Related]
18. Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity.
Gerard C; Chenoweth DE; Hugli TE
J Immunol; 1981 Nov; 127(5):1978-82. PubMed ID: 7299121
[No Abstract] [Full Text] [Related]
19. Complement activation by nylon- and polypropylene-looped prosthetic intraocular lenses.
Tuberville AW; Galin MA; Perez HD; Banda D; Ong R; Goldstein IM
Invest Ophthalmol Vis Sci; 1982 Jun; 22(6):727-33. PubMed ID: 7076418
[TBL] [Abstract][Full Text] [Related]
20. Quantification of C5a/C5a(desArg) in bovine plasma, serum and milk.
Rainard P; Sarradin P; Paape MJ; Poutrel B
Vet Res; 1998; 29(1):73-88. PubMed ID: 9559522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
